SFRP2 and cancer: Based on analysis of the SFRP2 promoter methylation status and the expression levels of SFRP2 in cancer tissues and adjacent non-cancer tissues from OSCC patients, the present study investigated the effects of SFRP2 on the Wnt signaling pathway in the development of OSCC in vivo and in vitro.